AF
ORMP icon

Aquamarine Financial’s Oramed Pharmaceuticals ORMP Stock Holding History

Aquamarine Financial’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1M Buy
2,512,175
+399,863
+19% +$1.59M 0.67% 10
2026
Q1 		$7.18M Buy
2,112,312
+139,255
+7% +$472K 0.53% 11
2025
Q4 		$5.62M Hold
1,973,057
– – 0.46% 9
2025
Q3 		$5.21M Buy
+1,973,057
New +$4.36M 0.53% 8

Other funds holding ORMP

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Aquamarine Financial's ORMP Position: Q2 2026 in Review

Aquamarine Financial increased its Oramed Pharmaceuticals (ORMP) stake by 19% in Q2 2026, buying an estimated $1.59M and bringing the position to 2,512,175 shares worth $12.1M. The position accounts for 0.67% of the portfolio, ranked #10.

Aquamarine Financial first reported a position in ORMP in Q3 2025 and has held it in 4 quarters since. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • Aquamarine Financial held 2,512,175 shares of Oramed Pharmaceuticals worth $12.1M as of Q2 2026.
  • Aquamarine Financial bought 399,863 Oramed Pharmaceuticals shares in Q2 2026, an estimated $1.59M.
  • Oramed Pharmaceuticals made up 0.67% of Aquamarine Financial's portfolio in Q2 2026, its #10 holding.
  • Aquamarine Financial first reported a position in Oramed Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Aquamarine Financial's 13F filing for Q2 2026, filed 12 Aug 2026.